Northwest Biotherapeutics Inc
OTC:NWBO

Watchlist Manager
Northwest Biotherapeutics Inc Logo
Northwest Biotherapeutics Inc
OTC:NWBO
Watchlist
Price: 0.28 USD 3.7% Market Closed
Market Cap: 389.4m USD

Intrinsic Value

NWBO's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

The intrinsic value of one NWBO stock under the Base Case scenario is 0.06 USD. Compared to the current market price of 0.28 USD, Northwest Biotherapeutics Inc is Overvalued by 79%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

NWBO Intrinsic Value
0.06 USD
Overvaluation 79%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Northwest Biotherapeutics Inc

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
NWBO
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for NWBO cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Northwest Biotherapeutics Inc
OTC:NWBO
US
Biotechnology
Market Cap
372m USD
IPO
Dec 14, 2001
US
Biotechnology
Market Cap
372m USD
IPO
Dec 14, 2001
Price
$false
EPS
$false
Company Overview
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about Northwest Biotherapeutics Inc
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Northwest Biotherapeutics Inc

Current Assets 4.1m
Cash & Short-Term Investments 2.2m
Other Current Assets 1.9m
Non-Current Assets 22.7m
PP&E 20.4m
Intangibles 1.9m
Other Non-Current Assets 365k
Efficiency

Free Cash Flow Analysis
Northwest Biotherapeutics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Northwest Biotherapeutics Inc

Revenue
1.4m USD
Operating Expenses
-67.9m USD
Operating Income
-66.5m USD
Other Expenses
-18.7m USD
Net Income
-85.2m USD
Fundamental Scores

NWBO Profitability Score
Profitability Due Diligence

Northwest Biotherapeutics Inc's profitability score is 45/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Year Average ROE
Negative Net Income
Exceptional ROE
ROE is Increasing
45/100
Profitability
Score

Northwest Biotherapeutics Inc's profitability score is 45/100. The higher the profitability score, the more profitable the company is.

NWBO Solvency Score
Solvency Due Diligence

Northwest Biotherapeutics Inc's solvency score is 17/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Positive Net Debt
Short-Term Solvency
17/100
Solvency
Score

Northwest Biotherapeutics Inc's solvency score is 17/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

NWBO Price Targets Summary
Northwest Biotherapeutics Inc

There are no price targets for NWBO.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Northwest Biotherapeutics Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for NWBO is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

NWBO Insider Trading
Buy and sell transactions by insiders

NWBO News

Other Videos
What is the Intrinsic Value of one NWBO stock?

The intrinsic value of one NWBO stock under the Base Case scenario is 0.06 USD.

Is NWBO stock undervalued or overvalued?

Compared to the current market price of 0.28 USD, Northwest Biotherapeutics Inc is Overvalued by 79%.

Back to Top